AI Article Synopsis

  • This study investigates the impact of botulinum toxin injections on seborrheic dermatitis symptoms in patients who also sought treatment for facial wrinkles, amid mixed research findings on this relationship.
  • Conducted as a clinical trial involving 20 participants, the study assessed changes in seborrheic dermatitis after one month of treatment using the Seborrheic Dermatitis Area and Severity Index (SDASI) for evaluation.
  • Results indicated a decrease in average symptom scores, but there was no statistically significant improvement in overall symptoms, leading to the conclusion that botulinum toxin is not recommended for managing seborrheic dermatitis.

Article Abstract

Introduction: Considering the proven therapeutic effect of botulinum toxin and the pathophysiology of seborrheic dermatitis, conflicting hypotheses have been put forward regarding the effect of injection of this toxin on the improvement or exacerbation of seborrheic dermatitis. Because of the lack of consistent studies investigating this relationship, we decided to conduct this study to investigate the effect of local botulinum toxin injection on sebum production and improvement or worsening of seborrheic dermatitis lesions.

Method: This study was a prospective, single-arm clinical trial that involved the injection of botulinum toxin into 20 patients with complaints of skin wrinkles and simultaneous symptoms of seborrheic dermatitis. The trial was conducted at a dermatology clinic between March 2019 and March 2021. Two important characteristics of these patients were seborrheic dermatitis on the face or scalp and a referral for botulinum toxin injection to remove facial wrinkles. The Seborrheic Dermatitis Area and Severity Index (SDASI) was used to determine the severity of symptoms.

Results: In study of 20 patients with an average age of 40 years, despite the decrease in the average scores of all examined criteria of seborrheic dermatitis symptoms in study, 1 month after botulinum toxin injection, no significant effect of using this toxin was seen on the improvement of patients' symptoms (p value >0.05).

Conclusion: Despite the emphasis of many studies on the effectiveness of botulinum toxin in reducing the activity of sebaceous glands, the use of botulinum toxin as a therapeutic modality for control the symptoms of seborrheic dermatitis is not suggested by this study. Conducting studies in which the location and technique of injection and the follow-up intervals of patients in them are based on the standard of other studies, are the suggestions made by comparing the results and method of the current study with other studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517391PMC
http://dx.doi.org/10.1111/srt.13478DOI Listing

Publication Analysis

Top Keywords

seborrheic dermatitis
36
botulinum toxin
32
toxin injection
16
toxin
10
seborrheic
9
dermatitis
9
dermatitis symptoms
8
prospective single-arm
8
single-arm clinical
8
clinical trial
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!